MedTrace Logo

Depression Therapy to Improve Cardiovascular Risk in HIV

NCT02309372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2020-07-14

Study results available
· View outcomes & findings →

Summary

This trial will determine if depression treatment will reduce cardiovascular risk in HIV-infected patients already receiving HIV treatments. Half of the participants will undergo a specific computerized depression treatment with the other half receiving usual care from their HIV providers.

Conditions

Interventions

BEHAVIORAL

Beating the Blues

Computerized depression treatment intervention

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Samir K Gupta, MD · Indiana University School of Medicine

  • Jesse C Stewart, PhD · Indiana University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309372 on ClinicalTrials.gov